Direxion Daily LLY Bear 1X Shares (NASDAQ:ELIS) Sees Large Increase in Short Interest

Direxion Daily LLY Bear 1X Shares (NASDAQ:ELIS) saw a significant growth in short interest in the month of September. As of September 30th, there was short interest totaling 5,000 shares, a growth of 257.1% from the September 15th total of 1,400 shares. Based on an average trading volume of 5,200 shares, the days-to-cover ratio is presently 1.0 days. Based on an average trading volume of 5,200 shares, the days-to-cover ratio is presently 1.0 days.

Direxion Daily LLY Bear 1X Shares Price Performance

Shares of NASDAQ:ELIS opened at $23.96 on Monday. The firm has a fifty day moving average price of $25.92 and a two-hundred day moving average price of $26.21. Direxion Daily LLY Bear 1X Shares has a one year low of $22.29 and a one year high of $31.30.

Direxion Daily LLY Bear 1X Shares Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 23rd were given a dividend of $0.1709 per share. This represents a $0.68 annualized dividend and a yield of 2.9%. The ex-dividend date was Tuesday, September 23rd.

Institutional Trading of Direxion Daily LLY Bear 1X Shares

An institutional investor recently bought a new position in Direxion Daily LLY Bear 1X Shares stock. Goldman Sachs Group Inc. acquired a new position in shares of Direxion Daily LLY Bear 1X Shares (NASDAQ:ELIS) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 25,000 shares of the company’s stock, valued at approximately $645,000. Goldman Sachs Group Inc. owned approximately 14.71% of Direxion Daily LLY Bear 1X Shares at the end of the most recent quarter.

Direxion Daily LLY Bear 1X Shares Company Profile

Direxion Shares ETF Trust – Direxion Daily LLY Bear 1X Shares is an exchange traded fund launched by Direxion Investments. The fund is managed by Rafferty Asset Management, LLC. It invests in public equity markets. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors.